Table 1.
First author | Publication year | Country | Sample size* | Mean of age | Male (%) | TST cut point | BCG vaccination | TST (+), QFT (+) | TST (−), QFT (+) | TST (+), QFT (−) | TST (−), QFT (−) |
---|---|---|---|---|---|---|---|---|---|---|---|
Seyhan EC | 2009 | Turkey | 72 | 56·2 | 0·47 | 10 | Yes | 17 | 17 | 13 | 25 |
Seyhan EC | 2009 | Turkey | 28 | 56 | – | – | No | 4 | 5 | 0 | 19 |
Ates G | 2009 | Turkey | 230 | 51·9 | 0·50 | 10 | Unclear | 58 | 49 | 25 | 98 |
Lee SSJ | 2010 | Taiwan | 93 | 58·3 | 0·41 | 5 | Unclear | Unclear | Unclear | Unclear | Unclear |
Lee SSJ | 2010 | Taiwan | – | – | – | 10 | Unclear | Unclear | Unclear | Unclear | Unclear |
Lee SSJ | 2010 | Taiwan | – | – | – | 15/10 | Unclear | Unclear | Unclear | Unclear | Unclear |
Lee SSJ | 2010 | Taiwan | – | – | – | 18/10 | Unclear | Unclear | Unclear | Unclear | Unclear |
Hoffmann M | 2010 | Switzerland | 32 | 64 | 0·48 | 10 | Unclear | 2 | 7 | 1 | 22 |
Hoffmann M | 2010 | Switzerland | – | – | – | 5 | Unclear | 5 | 4 | 2 | 21 |
Maden E | 2011 | Turkey | 67 | 54·8 | 0·51 | 10 | Yes | Unclear | Unclear | Unclear | Unclear |
Maden E | 2011 | Turkey | – | – | – | 5 | – | Unclear | Unclear | Unclear | Unclear |
Maden E | 2011 | Turkey | 29 | – | – | 10 | No | Unclear | Unclear | Unclear | Unclear |
Maden E | 2011 | Turkey | – | – | – | 5 | – | Unclear | Unclear | Unclear | Unclear |
Ahmadinejad Z | 2012 | Iran | 65 | 38·5 | 0·59 | 10 | Unclear | 6 | 8 | 7 | 30 |
Kim SY | 2013 | South Korea | 9 | 49 | 0·83 | 10 | Unclear | 4 | 2 | 0 | 3 |
Kim SY | 2013 | South Korea | 91 | 47 | 0·55 | 10 | Unclear | 11 | 27 | 5 | 48 |
Agrawal SK | 2015 | India | 185 | 36·7 | 0·70 | 10 | Unclear | 13 | 53 | 19 | 100 |
Sample size without indeterminate results.